… two blood pressure drugs, a cholesterol drug and a diabetes drug if …

… another pharmaceutical company, recalled a cholesterol medication after samples failed impurity tests … drops one, as 10,133 cholesterol drug bottles were involved. It was …

… decade. Merck’s non-statin cholesterol drug, enlicitide decanoate, was being tested …

… June. Merck’s non-statin cholesterol drug, enlicitide decanoate, was being tested …

MSD's oral drug met the main goal of reducing bad cholesterol in a late-stage trial, it said on Tuesday, marking a second win for the drug since June. The trial data provides a shot in the arm for the company, which is looking for its next blockbuster …

Basel: Swiss pharma major Novartis announced that its lipid-lowering therapy Leqvio (Inclisiran) showed early lipoprotein cholesterol (LDL-C) goal achievement with less muscle pain in a Phase IV study. Announcing the V-DIFFERENCE, Phase IV study results at …

Statins, which help treat high cholesterol, have been found to slow down the growth of colorectal tumours, according to a new study, making researchers consider the possibility of repurposing the drug to support cancer treatment. However, more clinical …

A recent study published in Engineering has shed light on the complex interactions between probiotics and drugs, particularly focusing on the effects of the probiotic Lacticaseibacillus paracasei Zhang (LCZ) on the cholesterol-lowering drug lovastatin. The …

… deletion syndrome – and that a cholesterol drug could restore barrier function and … a class of FDA-approved cholesterol drugs could potentially be repurposed to …